What is Elvie?
Elvie is a London-based innovator in the women's health technology sector, renowned for its patented pelvic floor trainer device. This sophisticated gadget employs a system of force and motion sensors to accurately measure pelvic floor muscle contractions, providing users with data-driven insights and guided exercises. Elvie's commitment to leveraging technology for discreet and effective health management positions it as a leader in the burgeoning femtech market. The company's focus on empowering women through accessible health solutions has garnered substantial backing, enabling further development and market expansion.
How much funding has Elvie raised?
Elvie has raised a total of $157M across 4 funding rounds:
Series A
$6M
Series B
$42M
Series C
$97M
Other Financing Round
$12M
Series A (2017): $6M with participation from Octopus Ventures and AllBright
Series B (2019): $42M, investors not publicly disclosed
Series C (2021): $97M supported by IPGL, Westerly Winds, and Hiro Capital
Other Financing Round (2024): $12M, investors not publicly disclosed
Key Investors in Elvie
Octopus Ventures
Octopus Ventures is a prominent UK-based investment firm known for its focus on high-growth companies, particularly in technology and healthcare sectors. They provide capital and strategic support to help businesses scale.
AllBright
AllBright is an organization dedicated to advancing women in business and leadership. Their investment likely reflects a commitment to supporting female-focused innovation and entrepreneurship.
IPGL
IPGL Limited is a private holding company that partners with management teams to build and grow businesses. Their investment in Elvie suggests a strategic interest in scalable, innovative companies.
What's next for Elvie?
With the recent influx of major strategic investment, Elvie is poised for accelerated growth and product development. This capital infusion is expected to fuel advancements in their technology, potentially expanding their product line and enhancing user experience. The company's consistent ability to attract significant funding, including Series B and Series C rounds, indicates a strong market position and a clear vision for the future of pelvic health. Elvie's strategic focus on innovation and market penetration, supported by its investors, suggests a continued expansion into global markets and a deepening impact on women's wellness.
See full Elvie company page
